Source: The New York Times
Whoop’s $10.1B valuation and $575M raise show that performance wearables have moved beyond a niche athlete accessory into a normalized health-monitoring category with real unit economics—the company’s claimed $1B ARR makes it one of the few fitness-tech companies to reach that threshold. The 60% international revenue mix exposes where growth actually lives: U.S. saturation is real, and Whoop’s ability to acquire customers in Europe and Asia at scale suggests the category’s next phase isn’t about better sensors or AI, but geographic arbitrage and distribution muscle in markets where health monitoring hasn’t yet consolidated around a single player.